Advertisement

Topics

Neuralstem, Inc. Company Profile

09:38 EDT 25th September 2017 | BioPortfolio

Neuralstem's patented technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells into mature, physiologically relevant human neurons and glia. The company is targeting major central nervous system diseases including: Ischemic Spastic Paraplegia, Traumatic Spinal Cord Injury, Huntington’s disease and Amyotrophic Lateral Sclerosis (ALS), often referred to as Lou Gehrig's disease. Neuralstem plans to initiate a Phase I clinical trial to treat ALS with its stem cells. ALS is a progressive fatal neurodegenerative disease that affects nerve cells in the brain, leading to the degeneration and death of the motor neurons in the spinal cord that control muscle movement. Pre-clinical work has shown Neuralstem’s cells to extend the life of rats with ALS (as reported in the journal TRANSPLANTATION, October 16, 2006, in collaboration with Johns Hopkins University researchers), and also to reverse paralysis in rats with Ischemic Spastic Paraplegia (as reported in NEUROSCIENCE, June 29, 2007, in collaboration with researchers at University of California San Diego).


News Articles [26 Associated News Articles listed on BioPortfolio]

Neuralstem FOPO nets $5.6mm

CNS drug developer Neuralstem Inc. netted $5.6mm through a public offering of 3mm common shares at $2.00. The company also issued seven-year warrants redeemable for 2.25mm common shares at $2.00. Rece...

Neuralstem Announces Top-line Phase 2 Data of NSI-189 for Major Depressive Disorder

GERMANTOWN, Md., July 25, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced top-line results ...

Neuralstem Is Doomed

Neuralstem's NSI-189 misses in Phase II for MDD

Neuralstem Announces Issuance of Two U.S. Patents

GERMANTOWN, Md., Sept. 07, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing novel treatments for nervous system diseases, today announced that it has...

Neuralstem sags after Phase II miss in MDD

NeuralStem Announces Issuance Of Two U.S. Patents

  Life Sciences Jobs   ...

Neuralstem Reports Last Subject Out in Phase 2 Trial of NSI-189 for Major Depressive Disorder

GERMANTOWN, Md., May 17, 2017 (GLOBE NEWSWIRE) -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company developing next generation treatments for nervous system diseases, today announced it ha...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [3 Associated Companies listed on BioPortfolio]

NeuralStem

Scientific founder and Chairman, Karl Johe, Ph.D. while at NINDS, NIH, originally developed Neuralstem’s technology. The Company’s other founders are current President & CEO Richard Garr, JD, and...

Neuralstem Inc.

Neuralstem's patented technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the d...

Neuralstem, Inc.

Neuralstem's patented technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability...

More Information about "Neuralstem, Inc." on BioPortfolio

We have published hundreds of Neuralstem, Inc. news stories on BioPortfolio along with dozens of Neuralstem, Inc. Clinical Trials and PubMed Articles about Neuralstem, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Neuralstem, Inc. Companies in our database. You can also find out about relevant Neuralstem, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Spinal Cord Disorders
The spinal cord is a bundle of nerves that runs down the middle of the back which carry signals back and forth between the body and brain. It is protected by vertebrae, which are the bone disks that make up the spine. An accident that damages the verte...

Anxiety Disorders
Anxiety is caused by stress. It is a natural reaction, and is beneficial in helping us deal with tense situations and pressure. It is deterimental when is becomes an excessive, irrational dread of everyday situations. The most common types of anxiety di...


Corporate Database Quicklinks



Searches Linking to this Company Record